Co-founder and VP Corporate Development at A3P Biomedical - Uppsala, Uppsala County, Sweden
The commercially available Stockholm3- test, is a blood-test for early detection of prostate cancer. A3P Biomedical's Stockholm3 test, combines protein markers, genetic markers and clinical data with an advanced algorithm in order to detect aggressive prostate cancer at early stage.